Inhalon Biopharma, Inc. (Inhalon), a clinical-stage company advancing a first-in-class inhaled antibody platform for treating acute respiratory infections (ARI), today announced the completion of ...
The purpose of this call for proposals is to support projects that seed new and unconventional ideas that could radically advance health equity for generations to come.
Quite frankly, Amaechi and El-Rufai were dead right. Nigerians are too docile and possess incredibly short-spanned memory. It is these two limitations that Nigerian politicians capitalise upon to ...